创金合信全球医药生物股票发起(QDII)A(018155)资产配置 |
|
|
| 报告日期 |
股票(元) |
债券(元) |
基金总资产(元) |
基金净值(元) |
股票占净值比 |
| 2025/12/31 |
742,005,000 |
- |
968,631,000 |
825,065,000 |
90% |
| 2025/9/30 |
33,743,400 |
- |
41,847,300 |
39,333,000 |
86% |
| 2025/6/30 |
11,707,000 |
- |
14,392,600 |
13,846,900 |
85% |
| 2025/3/31 |
10,455,100 |
- |
13,714,000 |
12,369,100 |
85% |
| 2024/12/31 |
10,222,100 |
- |
12,774,500 |
12,618,300 |
81% |
| 2024/9/30 |
10,793,700 |
- |
14,427,400 |
12,529,200 |
86% |
| 2024/6/30 |
8,442,560 |
- |
13,050,300 |
12,543,100 |
67% |
| 2024/3/31 |
10,312,300 |
- |
13,692,200 |
12,791,000 |
81% |
*注：新浪财经提醒：以上数据由合作伙伴提供，仅供参考，交易请以正式公告数据为准。
